SANTORO, ARMANDO
 Distribuzione geografica
Continente #
AS - Asia 434
NA - Nord America 228
EU - Europa 91
SA - Sud America 17
AF - Africa 8
Totale 778
Nazione #
US - Stati Uniti d'America 213
SG - Singapore 192
VN - Vietnam 100
CN - Cina 87
FR - Francia 38
BD - Bangladesh 26
IT - Italia 21
BR - Brasile 11
DE - Germania 8
HK - Hong Kong 7
SE - Svezia 7
CA - Canada 5
IE - Irlanda 5
TR - Turchia 4
MX - Messico 3
PH - Filippine 3
PL - Polonia 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BO - Bolivia 2
DK - Danimarca 2
EC - Ecuador 2
ES - Italia 2
FI - Finlandia 2
GB - Regno Unito 2
ID - Indonesia 2
IN - India 2
IQ - Iraq 2
LB - Libano 2
PK - Pakistan 2
UZ - Uzbekistan 2
BB - Barbados 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
MA - Marocco 1
MU - Mauritius 1
NL - Olanda 1
PA - Panama 1
PS - Palestinian Territory 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 778
Città #
Singapore 94
San Jose 68
Lauterbourg 35
Ashburn 34
Ho Chi Minh City 28
Hanoi 26
Boardman 17
Da Nang 8
New York 7
Beijing 6
Parma 6
Buffalo 5
Chandler 5
Dublin 5
Dallas 4
Los Angeles 4
Santa Clara 4
Council Bluffs 3
Denver 3
Hong Kong 3
Johannesburg 3
Munich 3
Nuremberg 3
Atlanta 2
Baku 2
Bologna 2
Can Tho 2
Copenhagen 2
Frankfurt am Main 2
Guangzhou 2
Haiphong 2
Montreal 2
Nanchang 2
Querétaro 2
Tashkent 2
Tân Tiến 2
Warsaw 2
Abbeville 1
Abidjan 1
Adana 1
Ambato 1
Ankara 1
Ann Arbor 1
Augusta 1
Baghdad 1
Barakaldo 1
Bari 1
Basra 1
Beau Bassin-Rose Hill 1
Beauchamps 1
Beirut 1
Bekasi 1
Bento Gonçalves 1
Biyala 1
Boston 1
Bridgetown 1
Burnaby 1
Bình Phước 1
Bến Tre 1
Cabo Frio 1
Casablanca 1
Castel Volturno 1
Chaguanas 1
Changsha 1
Charleston 1
Chennai 1
Chicago 1
Cleveland 1
Cochabamba 1
Contagem 1
Cuatro Cañadas 1
Esteio 1
Faisalabad 1
Genoa 1
Guarulhos 1
Helsinki 1
Hoi An 1
Huzhou 1
Huế 1
Hưng Yên 1
Hải Dương 1
Ituiutaba 1
Jakarta 1
Jiaxing 1
La Rochelle 1
Lahore 1
Leawood 1
London 1
Long An 1
Lấp Vò 1
Marseille 1
Mexico City 1
Milan 1
Modena 1
Nanjing 1
New Delhi 1
Norwalk 1
Olongapo City 1
Orem 1
Ottawa 1
Totale 465
Nome #
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer 116
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection 36
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications 33
Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: are we aware of the therapeutic impact of intratumor heterogeneity? 30
Direct-Acting Antiviral Agents in Hepatitis C–Associated Indolent Lymphomas 27
Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough? 24
Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 24
Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma 24
Tivantinib for Second-line Treatment of Advanced MET-High Hepatocellular Carcinoma: A Phase 3, Randomized, Placebo-Controlled Study (METIV-HCC) 23
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma 21
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study 21
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study 20
Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery? 20
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors 20
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 19
Pembrolizumab in MMR-proficient metastatic colorectal cancer pharmacologically primed to trigger dynamic hypermutation status: The ARETHUSA trial 19
Role of stereotactic body radiation therapy in the management of oligometastatic pancreatic cancer single institution experience 18
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study 18
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment 18
A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma 18
Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer 17
Reply to Y. Pointreau et al 16
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 16
Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study 16
COVID-19 and liver cancer clinical trials: not everything is lost 15
Prognostic value of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: an exploratory analysis from the second-line ARQ 197-215 study 15
Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection 14
Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer 14
Biomarkers in Hepatocellular Carcinoma-Letter 14
Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND) 14
Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study 13
Cabozantinib for the treatment of hepatocellular carcinoma 13
Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications 12
Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study 11
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach 10
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib 9
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomized, placebo-controlled phase 2 study 9
Sorafenib in hepatitis C-virus negative patients with hepatocellular carcinoma: don’t throw the baby out with the bathwater 8
Regorafenib for the treatment of unresectable hepatocellular carcinoma 8
Tivantinib for hepatocellular carcinoma 8
The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer 7
Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma 7
Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma 6
Totale 821
Categoria #
all - tutte 3.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.415


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 1 0 0 0 1
2022/202318 3 3 1 1 1 2 0 1 6 0 0 0
2023/20247 0 2 0 0 1 2 0 1 0 0 0 1
2024/202523 0 1 1 3 2 3 0 0 4 1 3 5
2025/2026758 5 4 5 3 104 115 138 83 122 109 47 23
Totale 821